SEARCH:   Advanced

Blood, 15 October 2006, Vol. 108, No. 8, pp. 2509-2519. Prepublished online as a Blood First Edition Paper on June 15, 2006; DOI 10.1182/blood-2006-03-010777. This Article Full Text Full Text (PDF) All Versions of this Article: blood-2006-03-010777v1 108/8/2509    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Young, N. S. Articles by Scheinberg, P. Search for Related Content PubMed PubMed Citation Articles by Young, N. S. Articles by Scheinberg, P. Related Collections Immunobiology Red Cells Reviews in Translational Hematology Clinical Trials and Observations Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  REVIEW IN TRANSLATIONAL HEMATOLOGY Current concepts in the pathophysiology and treatment of aplastic anemia Neal S. Young, Rodrigo T. Calado, and Phillip Scheinberg From the Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone marrow failure syndromes. Almost universally fatal just a few decades ago, aplastic anemia can now be cured or ameliorated by stem-cell transplantation or immunosuppressive drug therapy. The pathophysiology is immune mediated in most cases, with activated type 1 cytotoxic T cells implicated. The molecular basis of the aberrant immune response and deficiencies in hematopoietic cells is now being defined genetically; examples are telomere repair gene mutations in the target cells and dysregulated T-cell activation pathways. Immunosuppression with antithymocyte globulins and cyclosporine is effective at restoring blood-cell production in the majority of patients, but relapse and especially evolution of clonal hematologic diseases remain problematic. Allogeneic stem-cell transplant from histocompatible sibling donors is curative in the great majority of young patients with severe aplastic anemia; the major challenges are extending the benefits of transplantation to patients who are older or who lack family donors. Recent results with alternative sources of stem cells and a variety of conditioning regimens to achieve their engraftment have been promising, with survival in small pediatric case series rivaling conventional transplantation results. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: J. L. Espinoza, H. Takamatsu, X. Lu, Z. Qi, and S. Nakao Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-{alpha} through an ERK1/2-dependent pathway Int. Immunol., June 25, 2009; (2009) dxp058v1. [Abstract] [Full Text] [PDF] R. A. Brodsky How I treat paroxysmal nocturnal hemoglobinuria Blood, June 25, 2009; 113(26): 6522 - 6527. [Abstract] [Full Text] [PDF] C. J. Stotler, B. Eghtesad, E. Hsi, and B. Silver Rapid resolution of GVHD after orthotopic liver transplantation in a patient treated with alefacept Blood, May 21, 2009; 113(21): 5365 - 5366. [Full Text] [PDF] F. O. Pinto, T. Leblanc, D. Chamousset, G. Le Roux, B. Brethon, B. Cassinat, J. Larghero, J.-P. de Villartay, D. Stoppa-Lyonnet, A. Baruchel, et al. Diagnosis of Fanconi anemia in patients with bone marrow failure Haematologica, April 1, 2009; 94(4): 487 - 495. [Abstract] [Full Text] [PDF] S. O. Omokaro, M. J. Desierto, M. A. Eckhaus, F. M. Ellison, J. Chen, and N. S. Young Lymphocytes with Aberrant Expression of Fas or Fas Ligand Attenuate Immune Bone Marrow Failure in a Mouse Model J. Immunol., March 15, 2009; 182(6): 3414 - 3422. [Abstract] [Full Text] [PDF] J. R. Passweg and A. Tichelli Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica, March 1, 2009; 94(3): 310 - 312. [Full Text] [PDF] X. Hu, Y. Gu, Y. Wang, Y. Cong, X. Qu, and C. Xu Increased CD4+ and CD8+ effector memory T cells in patients with aplastic anemia Haematologica, March 1, 2009; 94(3): 428 - 429. [Full Text] [PDF] J.-S. Delisle, L. Gaboury, M.-P. Belanger, E. Tasse, H. Yagita, and C. Perreault Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-{gamma} receptor-deficient hosts Blood, September 1, 2008; 112(5): 2111 - 2119. [Abstract] [Full Text] [PDF] E. Montane, L. Ibanez, X. Vidal, E. Ballarin, R. Puig, N. Garcia, J.-R. Laporte, and the Catalan Group for the Study of Agranulocytosis Epidemiology of aplastic anemia: a prospective multicenter study Haematologica, April 1, 2008; 93(4): 518 - 523. [Abstract] [Full Text] [PDF] E. E. Solomou, K. Rezvani, S. Mielke, D. Malide, K. Keyvanfar, V. Visconte, S. Kajigaya, A. J. Barrett, and N. S. Young Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia Blood, September 1, 2007; 110(5): 1603 - 1606. [Abstract] [Full Text] [PDF] V. Trisal, A. Nademanee, S. K. Lau, and F. W. Grannis Jr Thymoma-Associated Severe Aplastic Anemia Treated With Surgical Resection Followed by Allogeneic Stem-Cell Transplantation J. Clin. Oncol., August 1, 2007; 25(22): 3374 - 3375. [Full Text] [PDF] K.-i. Sawada, M. Hirokawa, N. Fujishima, M. Teramura, M. Bessho, K. Dan, H. Tsurumi, S. Nakao, A. Urabe, M. Omine, et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group Haematologica, August 1, 2007; 92(8): 1021 - 1028. [Abstract] [Full Text] [PDF] E. E. Solomou, F. Gibellini, B. Stewart, D. Malide, M. Berg, V. Visconte, S. Green, R. Childs, S. J. Chanock, and N. S. Young Perforin gene mutations in patients with acquired aplastic anemia Blood, June 15, 2007; 109(12): 5234 - 5237. [Abstract] [Full Text] [PDF] H. Sukati, H. G. Watson, S. J. Urbaniak, and R. N. Barker Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura Blood, May 15, 2007; 109(10): 4528 - 4538. [Abstract] [Full Text] [PDF] S. Maury, M.-L. Balere-Appert, Z. Chir, J.-M. Boiron, C. Galambrun, K. Yakouben, P. Bordigoni, A. Marie-Cardine, N. Milpied, J. Kanold, et al. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient Haematologica, May 1, 2007; 92(5): 589 - 596. [Abstract] [Full Text] [PDF] P. Scheinberg, S. H. Fischer, L. Li, O. Nunez, C. O. Wu, E. M. Sloand, J. I. Cohen, N. S. Young, and A. John Barrett Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia Blood, April 15, 2007; 109(8): 3219 - 3224. [Abstract] [Full Text] [PDF] J. Chen, F. M. Ellison, M. A. Eckhaus, A. L. Smith, K. Keyvanfar, R. T. Calado, and N. S. Young Minor Antigen H60-Mediated Aplastic Anemia Is Ameliorated by Immunosuppression and the Infusion of Regulatory T Cells J. Immunol., April 1, 2007; 178(7): 4159 - 4168. [Abstract] [Full Text] [PDF] A. Bacigalupo Aplastic Anemia: Pathogenesis and Treatment Hematology, January 1, 2007; 2007(1): 23 - 28. [Abstract] [Full Text] [PDF] G. C. Bagby and G. Meyers Bone Marrow Failure as a Risk Factor for Clonal Evolution: Prospects for Leukemia Prevention Hematology, January 1, 2007; 2007(1): 40 - 46. [Abstract] [Full Text] [PDF]

	Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020